Circulating Biomarkers of Cardiopulmonary Disturbances in COVID-19

Significant findings have been obtained on the relationship between underlying cardiovascular disease and the severity of COVID-19 infection. Using plasma profiles of patients with COVID-19, biomarkers in circulation were also identified that varied depending on the patient's characteristics and disease. The purpose of this study is to review the sources that focus on circulating biomarkers of cardiopulmonary disorders. In addition to conventional biomarkers such as troponin, we consider data from new emerging biomarkers about their roles in the prognosis of severity, mortality in the hospital and effectiveness of treatment. Consideration of mechanisms associated with circulating biomarkers in various conditions associated with COVID-19 can provide broader tools for the diagnosis, treatment, and prognosis of at-risk patients

Keywords: Circulating Biomarkers, Prognosis, Severity, Cardiopulmonary Disorders, COVID-19.